EXCLUSIVE: DEA-Licensed Cannabis Co. Maridose To Launch Series A Funding Round At Upcoming Benzinga Conference
Maridose LLC, a company recognized for its contributions to the field of legalized medical cannabis research and product development, and one of the select few companies to have been granted a license by the U.S. Drug Enforcement Administration (DEA) to legally produce cannabis for research purposes, will be launching its Series A funding round at the upcoming Benzinga Cannabis Capital Conference, set to take place on April 16 – 17, 2024, at the Diplomat Beach Resort in Hollywood, Florida,
This development marks a significant shift in the landscape of cannabis research in the United States, which has been tightly regulated since 1968, with the University of Mississippi being the sole producer of legal cannabis for research. Maridose’s entry into this space signifies the end of this monopoly and the beginning of new opportunities for commercial product development and private investment in cannabis research.
Leading the scientific charge at Maridose is Prof. Lumír Ondřej …